Integrated report 2020

 Menu

Currently viewing: Our strategy / Next: Chairman's review

Our strategy

OUR VISION

To be a global, people-centred, diversified healthcare organisation.

OUR STRATEGIC INTENT


Global healthcare provider
Offering an integrated healthcare model and diagnostic imaging capability
Diversified offering
With a growing share of revenue and earnings from non-acute sources
Clinical excellence, analytics and technology
Focus on our employees, clinicians, clinical excellence and using analytics and technology to positively impact patient care

OUR FOUNDATION – OUR FOUR STRATEGIC PILLARS


Growth

Efficiency

Quality

Sustainability

OUR STRATEGIC ENABLERS

Technology
Our technology and infrastructure will underpin future digital enablement and ways of working.
Data and analytics
Ultimately, we want analytics to be a key competitive differentiator that enable adaptable, innovative, decisive and insight driven decisions.
Our people
With skilled and dedicated professionals, we are assured of clinical excellence. We will continue to retain and attract the best talent in the market.
OUR STRATEGIC GOALS
How we get there
Our key measures

Become an employer of choice within the regions we operate

Ensuring that we attract, develop and retain the best talent in each of our markets

  • Employee turnover rate,
  • Number of nurses enrolled in training,
  • Total spend on training and development,
  • Number of employees involved in education, training and development
How we get there

Deliver clinical excellence and a leading patient experience

Aligning clinical performance with evidence and consensus-based best practice

Our key measures
  • Quality metrics published
  • Patient experience
How we get there

Deliver operational excellence

Resulting in excellent operating margins, return on capital and improved capital efficiency

Our key measures
  • EBITDA and EBITA margin
  • Normalised EPS, headline EPS
  • Return on capital employed (ROCE)
  • Capital expenditure
How we get there

Increase non-acute revenue and earnings

Enhancing our diagnostic imaging footprint and expand along the continuum of care – creating an integrated healthcare model

Our key measures
  • Percentage of revenue and earnings from non-acute services
How we get there

Optimise our clinical and operational performance

Leveraging technology, data and analytics

Our key measures
  • Key clinical indicators
  • Serious reportable IT events
  • Analytics business as usual (BAU) and innovation
How we get there

Develop long-term relationships with our stakeholders

Focusing on our clinicians, suppliers, and private and public sector funders

Our key measures
  • Funder engagement
  • Investor and employee opinion
  • Procurement and supplier satisfaction scoring
How we get there

Create a culture that embeds transformation, diversity and inclusion

Our key measures
  • B-BBEE scores
  • Diversity measures
HOW WE GROW
Focusing on:
Diagnostic imaging in southern Africa

As the leading independent provider of medical imaging services in Europe, we plan to harness Alliance Medical’s expertise to offer high-quality, affordable diagnostic services in South Africa.

Outpatient care

We want to broaden our healthcare delivery across the continuum of care by further expanding into step down, sub-acute and homecare services. Improve healthcare access and affordability by offering the employed uninsured population convenient, quality, nurse-led outpatient care via technology and scaled through partnerships.

LMI

Innovative PET radiopharmaceuticals improve the diagnosis of life-threatening diseases in neurology, oncology and cardiology. We plan to drive commercial sales of Neuraceq™, develop and commercialise our pipeline of products that address major unmet clinical needs in neurological, oncological and cardiovascular diseases.

Government

We work with local governments across the Group, delivering access to high-quality care. Our intention is to strengthen these partnerships through excellent service delivery and ongoing support.

Back to top